DECEMBER 4, 2019
Biophytis to attend 11th Geneva MidCap Event. Read the Press Release
Biophytis to attend 11th Geneva MidCap Event. Read the Press Release
Biophytis to participate in the 6th China Healthcare Summit organized by BioCentury and BayHelix in Shanghai. Read the Press Release
Biophytis Files IND Application with FDA for Sarconeos (BIO101) to Support Planned MYODA Clinical Program in Patients with DMD. Read the Press Release
Biophytis to attend BIO-Europe® in Hamburg. Read the Press Release
Biophytis Files Protocol Amendment to Optimize the SARA-INT Phase 2b Clinical Trial for Sarcopenia. Read the Press Release
Biophytis Reports H1 2019 Financial Results and Provides Business Update. Read the Press Release
Biophytis to attend The Galien MedStartUp 2019 Event in New York. Read the Press Release
Biophytis to attend the European Large & MidCap Event in Paris. Read the Press Release[
Biophytis Opens 22nd Clinical Site in the SARA-INT Phase 2b Trial of Sarconeos (BIO101) for the Treatment of Sarcopenia. Read the Press Release
Biophytis to Present Four Posters at the 24th Annual Congress of the World Muscle Society (WMS) in Copenhagen, Denmark. Read the Press Release